CME Group initiated with an Overweight at Barclays

Barclays analyst Benjamin Budish initiated coverage of CME Group with an Overweight rating and $215 price target. CME is the largest exchange operator in the world, “with a long history of solid organic volume growth and strong competitive moats,” the analyst tells investors in a research note. In addition, the stock’s valuation premium versus the peer group has recently narrowed, making the shares attractive at current levels, says the firm.